Wegovy and an Elevated Heart Rate: What's Actually Happening

Is a faster pulse after starting Wegovy normal, or a warning sign?

This is the decision most people are wrestling with when they land on this question. A small rise in resting heart rate is documented in semaglutide trials and is listed in the Wegovy summary of product characteristics — so in that sense it can be a normal physiological response to the medicine. GLP-1 receptor agonists act on receptors found not just in the gut but also in the heart and autonomic nervous system, and that interaction can nudge resting pulse upward by a few beats. For most people the increase is minor and they never consciously feel it.

What distinguishes expected from concerning is a combination of magnitude, timing, and accompanying symptoms. A resting pulse running a few beats faster than your norm in the first few weeks after starting or increasing a dose is well within the documented range, and our page on what causes a fast heart rate on Wegovy goes into the mechanisms behind this in more detail. A pulse that feels rapid enough to interrupt sleep, comes with chest pain, breathlessness or faintness, or that does not settle between dose steps, belongs in a different category entirely. The NHS medicines information for semaglutide notes palpitations and increased heart rate among effects to be aware of, and recommends contacting a doctor if they are troublesome. If you want to get a sense of your baseline, a 60-second manual check at rest (count the beats on your wrist for a full minute, mid-morning before coffee) takes under a minute and gives you a number to share with your prescriber rather than an impression.

The honest answer is that this effect sits on a spectrum, and where you land on it depends on your individual physiology, your starting cardiovascular health, and the dose you are on. That is exactly the kind of nuance a prescriber weighs at assessment.

What the clinical evidence actually found

The STEP programme of trials, which formed the basis of Wegovy's licensing, tracked cardiovascular parameters alongside weight outcomes. Across STEP 1 and related studies, participants on semaglutide 2.4 mg showed a small mean increase in heart rate compared with placebo — in the range of about 1–4 beats per minute at population level. That figure is an average, which means some participants saw no change and a smaller number saw more. The increase tended to appear early and remain roughly stable rather than continuing to climb with time, and it did not translate into a clinically meaningful cardiovascular harm signal in the main STEP populations.

The NHS semaglutide medicines page lists increased heart rate as a known effect and advises telling your doctor or pharmacist if it becomes bothersome. That framing (bothersome, not alarming) reflects the clinical consensus for the majority of users. However, semaglutide also holds a separate licence for reducing the risk of major cardiovascular events in adults with established heart disease, which suggests that for appropriately assessed patients the overall cardiac profile is not harmful. The key phrase there is appropriately assessed: the medicine is not suitable for everyone, and your full cardiac history is part of what a prescriber needs to see before any treatment begins.

For a broader look at how semaglutide interacts with heart rhythm specifically, our page on how Wegovy affects heart rate covers the physiology in more detail.

When to stop waiting and get medical help

There is a clear line between an effect worth monitoring and one worth acting on, and it is worth stating plainly. Contact your GP, call 111, or go to A&E depending on severity if you experience any of the following: a heart rate that feels very fast or irregular at rest, chest pain or pressure, breathlessness at rest or on minimal activity, dizziness or fainting, or a sense that your heart is pounding continuously. None of these are explained away by Wegovy and none should be attributed to it without clinical assessment.

You should also tell your prescriber if you have a personal or family history of long QT syndrome, significant arrhythmia, or recent cardiac events, as these may affect whether semaglutide is appropriate for you at all. It is also worth noting that dehydration from gastrointestinal side effects (nausea and vomiting are common in the early weeks) can itself raise heart rate, and if you are also noticing changes in your liver function tests it is worth reading about whether semaglutide can cause elevated liver enzymes so you have the full picture to share with your prescriber. The MHRA's Yellow Card scheme exists so that patients can report unexpected or severe reactions directly, which helps regulators track real-world safety signals across the population.

If you are unsure whether what you are experiencing falls into the expected or the concerning category, the right move is to contact your prescriber rather than search for reassurance online. Our support team is available seven days a week to help you reach the right person quickly.

How a prescriber weighs this risk before starting treatment

At a reputable online pharmacy, a prescriber does not simply tick a BMI box and issue a script. Before Wegovy is appropriate for anyone, the clinician needs to understand your baseline cardiovascular status, existing conditions, medications that might interact, resting pulse, blood pressure history, and any symptoms that might point to an underlying arrhythmia, and our page on managing a high heart rate on Wegovy outlines what that monitoring can look like in practice. For people on beta-blockers or other rate-controlling medicines, or those with a documented cardiac condition, that conversation is even more important.

At nume, every consultation is read personally by a GPhC-registered Independent Prescriber the same day it is submitted. There is no automated decision, a real clinician reads your answers, considers your health history, and decides whether treatment is clinically suitable. Transfer patients and those requesting dose increases go through an additional evidence-review step. If you are weighing up whether Wegovy is right for you given your heart health, the free consultation is the right starting point; the prescriber can raise or investigate any cardiac concerns before anything is dispensed. You can also read more about Wegovy as a treatment to understand the full clinical picture, or explore all licensed weight-loss treatments if you want to compare options. For questions about cost and what is included in a private prescription, our Wegovy prescription page sets that out plainly.